CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net loss	$ (3,540,825)	$ (4,111,844)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,318	3,318
Equity-based compensation expense	79,535	222,685
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(502,224)	506,888
Accounts payable	27,132	(437,052)
Accrued expenses and other current liabilities	242,364	33,186
Net cash used in operating activities	(3,690,700)	(3,782,819)
Investing activities
Short Term Promissory Note	(200,000)	0
Net cash used in investing activities	(200,000)	0
Financing activities
Proceeds from issuance of equity securities, net	6,487,718	1,526,460
Payments on note payable	(221,866)	(359,522)
Net cash provided by (used in) provided by financing activities	6,265,852	1,166,938
Net decrease in cash and cash equivalents	2,375,152	(2,615,881)
Cash and cash equivalents at beginning of period	2,434,528	5,899,910
Cash and cash equivalents at end of period	4,809,680	3,284,029
Non-cash investing and financing activities:
Cash paid for interest	5,800	12,064
Accrued issuance costs for issuance of equity securities	290,058	0
Insurance premium financed by note payable	$ 0	$ 398,728